<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03211351</url>
  </required_header>
  <id_info>
    <org_study_id>FSHX-001</org_study_id>
    <nct_id>NCT03211351</nct_id>
  </id_info>
  <brief_title>Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome</brief_title>
  <official_title>Comparison of the Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Huaxia Eye Hospital Group</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Huaxia Eye Hospital Group</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      With the potential to address evaporative dry eye, Liposic and Tears Naturale Forte have been
      developed in which phospholipid liposomes are delivered to the tear film via the surface of
      the closed eyelid. This study compare the effects of Liposic and Tears Naturale Forte
      application on the lipid and stability of the tear film in dry eye patients
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 1, 2017</start_date>
  <completion_date type="Actual">January 25, 2018</completion_date>
  <primary_completion_date type="Actual">December 1, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>scale of Schirmer I test</measure>
    <time_frame>up to 3 months after tear substitutes apply</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>scale of corneal fluorescein staining</measure>
    <time_frame>up to 3 months after tear substitutes apply</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>scale of noninvasive tear breakup time</measure>
    <time_frame>up to 3 months after tear substitutes apply</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>scale of tear meniscus height</measure>
    <time_frame>up to 3 months after tear substitutes apply</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>lipid layer grade</measure>
    <time_frame>up to 3 months after tear substitutes apply</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>questionnaire of ocular surface disease index</measure>
    <time_frame>up to 3 months after tear substitutes apply</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>subjective comfort</measure>
    <time_frame>up to 3 months after tear substitutes apply</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">95</enrollment>
  <condition>Dry Eye</condition>
  <condition>Tear Film</condition>
  <condition>Lipid Layer</condition>
  <condition>Liposic</condition>
  <condition>Tears Naturale Forte</condition>
  <arm_group>
    <arm_group_label>Liposic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Liposic was applied to one eye of patients in this group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tears Naturale Forte</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Tears Naturale Forte was applied to one eye of patients in this group</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Liposic</intervention_name>
    <description>one eye of the participant recieved Lipoic</description>
    <arm_group_label>Liposic</arm_group_label>
    <other_name>Carbomer</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tears Naturale Forte</intervention_name>
    <description>the other eye of the participant recieved Tears Naturale Forte</description>
    <arm_group_label>Tears Naturale Forte</arm_group_label>
    <other_name>DEXTRAN/HYPROMELLOSE/GLYCERIN</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age range from 20 year to 40 years

          -  The value of OSDI is over 12

          -  NBUT is less 5 seconds

          -  Schirmer 1 test is less 10mm

          -  The basical lipid layer grade is 1-2

        Exclusion Criteria:

          -  Any corneal,conjunctival, or eyelid abnormalities; conjunctivitis; current ocular
             infection; photophobia that may cause reflex tearing or difficulty in evaluating the
             patien 's lipid layer;

          -  Known allergic sensitivity to any of the ingredients in Liposic or Tears Naturale
             Forte
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chi Zhang, MD.PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Huaxia Eye Hospital of Foshan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Huaxia Eye Hosptial of Foshan</name>
      <address>
        <city>Foshan</city>
        <state>Guangdong</state>
        <zip>528000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 5, 2017</study_first_submitted>
  <study_first_submitted_qc>July 5, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 7, 2017</study_first_posted>
  <last_update_submitted>February 22, 2018</last_update_submitted>
  <last_update_submitted_qc>February 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratoconjunctivitis Sicca</mesh_term>
    <mesh_term>Dry Eye Syndromes</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dextrans</mesh_term>
    <mesh_term>Glycerol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

